🇺🇸 FDA
Patent

US 11214595

BK channel-modulating peptides and their use

granted A61KA61K38/00A61K38/08

Quick answer

US patent 11214595 (BK channel-modulating peptides and their use) held by The Board of Regents of the University of Texas System expires Mon Dec 30 2041 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
The Board of Regents of the University of Texas System
Grant date
Tue Jan 04 2022 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Dec 30 2041 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
10
CPC classes
A61K, A61K38/00, A61K38/08, A61K38/12, A61K47/64